Cyclopentadienyl complexes of general formula [RuX(η 5 -ligand)(PR 3 ) 2 ] have been found to catalyze the stereoselective decomposition of ethyl diazoacetate (EDA) to form diethyl maleate (DEM) in 95−99% purity with less than 1 mol % of catalyst, at temperatures depending on the bulkiness of the phosphine and the η 5 -ligand as well as the nature of the anionic ligand X. A detailed study of the reaction between [RuCl(η 5 -C 5 H 5 )(PPh 3 ) 2 ] and EDA suggests that dissociation of one PPh 3 is a key step of the catalytic process, which proceeds via the intermediate [RuCl(η 5 -C 5 H 5 )( CHCO 2 Et)(PPh 3 )]. Although this electrophilic carbene was not detected in the reaction mixture, it was independently prepared in solution at low temperature starting from [Ru(η 2 -O 2 CMe)(η 5 -C 5 H 5 )(PPh 3 ). The acetate reacts with EDA at −40 °C to form the cyclic ester which on treatment with Me 2 SiCl 2 gives the metal carbene postulated in the catalytic cycle. The stoichiometric reaction of the latter compound with EDA selectively affords the olefin derivative [RuCl(η 5 -C 5 H 5 )(η 2 -DEM)(PPh 3 )], which was also detected in the catalytic cycle. The new complexes [RuCl(η 5 -C 5 H 5 )(PR 3 ) 2 ] (PR 3 = PPh 2 (2-MeC 6 H 4 ), PPh 2 Cy, P(3-MeC 6 H 4 ) 3 ), bearing phosphines bulkier than PPh 3, have been prepared in high yield starting from ruthenium trichloride hydrate, cyclopentadiene, and phosphine in refluxing ethanol.
No takes yet. Share an insight, caveat, or question.
Baratta et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: